Literature DB >> 10924508

Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage.

P Sivasothy1, T R Dafforn, P G Gettins, D A Lomas.   

Abstract

alpha(1)-Antitrypsin is the most abundant circulating protease inhibitor and the archetype of the serine protease inhibitor or serpin superfamily. Members of this family may be inactivated by point mutations that favor transition to a polymeric conformation. This polymeric conformation underlies diseases as diverse as alpha(1)-antitrypsin deficiency-related cirrhosis, thrombosis, angio-edema, and dementia. The precise structural linkage within a polymer has been the subject of much debate with evidence for reactive loop insertion into beta-sheet A or C or as strand 7A. We have used site directed cysteine mutants and fluorescence resonance energy transfer (FRET) to measure a number of distances between monomeric units in polymeric alpha(1)-antitrypsin. We have then used a combinatorial approach to compare distances determined from FRET with distances obtained from 2.9 x 10(6) different possible orientations of the alpha(1)-antitrypsin polymer. The closest matches between experimental FRET measurements and theoretical structures show conclusively that polymers of alpha(1)-antitrypsin form by insertion of the reactive loop into beta-sheet A.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924508     DOI: 10.1074/jbc.M004054200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Alpha-1 antitrypsin deficiency.

Authors:  R A Primhak; M S Tanner
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

2.  Probing serpin conformational change using mass spectrometry and related methods.

Authors:  Yuko Tsutsui; Anindya Sarkar; Patrick L Wintrode
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

3.  Protein fiber linear dichroism for structure determination and kinetics in a low-volume, low-wavelength couette flow cell.

Authors:  Timothy R Dafforn; Jacindra Rajendra; David J Halsall; Louise C Serpell; Alison Rodger
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

Review 4.  How do proteins avoid becoming too stable? Biophysical studies into metastable proteins.

Authors:  Lisa D Cabrita; Stephen P Bottomley
Journal:  Eur Biophys J       Date:  2003-09-19       Impact factor: 1.733

Review 5.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

6.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.

Authors:  Lawrence C Thompson; Sumit Goswami; David S Ginsberg; Duane E Day; Ingrid M Verhamme; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

7.  pH induces thermal unfolding of UTI: an implication of reversible and irreversible mechanism based on the analysis of thermal stability, thermodynamic, conformational characterization.

Authors:  Handong Fan; Jing Liu; Wendan Ren; Zhongliang Zheng; Yuying Zhang; Xi Yang; Huaping Li; Xiaoyan Wang; Guolin Zou
Journal:  J Fluoresc       Date:  2007-11-09       Impact factor: 2.217

Review 8.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

9.  The structural basis of serpin polymerization studied by hydrogen/deuterium exchange and mass spectrometry.

Authors:  Yuko Tsutsui; Barbara Kuri; Tanusree Sengupta; Patrick L Wintrode
Journal:  J Biol Chem       Date:  2008-09-15       Impact factor: 5.157

10.  Polymerization of human angiotensinogen: insights into its structural mechanism and functional significance.

Authors:  Peter Stanley; Louise C Serpell; Penelope E Stein
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.